Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer
Anticancer Research · 2026
DOI: 10.21873/anticanres.18014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Yuki Seki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Nutrition Assessment, Geriatric Assessment.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; fbxbj429@ybb.ne.jp.
- Department of Breast Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Zitieren
APA
Seki, Y., Shibutani, M., Tanda, H., Tsukida, T., Kasashima, H., Kashiwagi, S., & Maeda, K. (2026). Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18014
Vancouver
Seki Y, Shibutani M, Tanda H, Tsukida T, Kasashima H, Kashiwagi S, et al. Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18014
BibTeX
@article{Seki2026,
author = {Seki, Yuki and Shibutani, Masatsune and Tanda, Hideki and Tsukida, Tomoya and Kasashima, Hiroaki and Kashiwagi, Shinichiro and Maeda, Kiyoshi},
title = {Impact of the Immunonutritional Status on the Feasibility of Subsequent Treatment After the Discontinuation of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients With Metastatic Colorectal Cancer},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18014}
}
EUVIMED